DİKCİ, S. Et Al. 2018. Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.81, no.1 , 12-17.

DİKCİ, S., CEYLAN, O. M., DEMİREL, S., & Yilmaz, T., (2018). Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.81, no.1, 12-17.

DİKCİ, SEYHAN Et Al. "Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?," ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.81, no.1, 12-17, 2018

DİKCİ, SEYHAN Et Al. "Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?." ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.81, no.1, pp.12-17, 2018

DİKCİ, S. Et Al. (2018) . "Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?." ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.81, no.1, pp.12-17.

@article{article, author={SEYHAN DİKCİ Et Al. }, title={Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?}, journal={ARQUIVOS BRASILEIROS DE OFTALMOLOGIA}, year=2018, pages={12-17} }